Cargando…

Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study

BACKGROUND: Excess mortality in gout has been attributed to cardiovascular diseases (CVD). Considering the decline in CVD mortality in the general population, we wanted to evaluate overall mortality in gout and cause-specific contributions to mortality beyond CVD and temporal trends. METHODS: All in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehlin, Mats, Sandström, Tatiana Zverkova, Jacobsson, Lennart TH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907510/
https://www.ncbi.nlm.nih.gov/pubmed/35280894
http://dx.doi.org/10.3389/fmed.2022.802856
_version_ 1784665660942450688
author Dehlin, Mats
Sandström, Tatiana Zverkova
Jacobsson, Lennart TH
author_facet Dehlin, Mats
Sandström, Tatiana Zverkova
Jacobsson, Lennart TH
author_sort Dehlin, Mats
collection PubMed
description BACKGROUND: Excess mortality in gout has been attributed to cardiovascular diseases (CVD). Considering the decline in CVD mortality in the general population, we wanted to evaluate overall mortality in gout and cause-specific contributions to mortality beyond CVD and temporal trends. METHODS: All incident cases of gout between 2006 and 2015 in western Sweden and 5 population controls per case matched for age, sex, and county were identified. Comorbidities were identified for 5 years preceding the index date. Follow-up ended at death, migration, or end of study on December 2017. Effect of gout on death risk was calculated using COX regression on the whole population and stratified by sex, adjusted for demographics, and comorbidities. Death incidence rates were compared between the two time periods, 2006–2010 and 2011–2015. RESULTS: We identified 22,055 cases of incident gout and 98,946 controls, median age (Q1, Q3) 69–68 (57, 79/56, 78) years and 67.6–66.5% males. Except for dementia, all comorbidities were significantly more common at baseline among gout cases. Overall, the risk for death in incident gout was neither increased overall nor in men, but women had a 10% elevated risk. In adjusted models for cause-specific mortality, death from CVD, renal disease, and digestive system diseases were significantly increased in the total gout population while death from dementia, cancer, and lung diseases were significantly decreased. There were no significant differences in overall incident death rate ratios between cases and controls in the two time periods examined. CONCLUSIONS: An increased risk for CVD, renal disease, and diseases of the digestive system in patients with gout highlights the importance of addressing CVD risk factors in gout management. Gout was associated with reduced mortality from dementia, which may have implications on urate lowering therapy and possible effects on dementia risk.
format Online
Article
Text
id pubmed-8907510
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89075102022-03-11 Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study Dehlin, Mats Sandström, Tatiana Zverkova Jacobsson, Lennart TH Front Med (Lausanne) Medicine BACKGROUND: Excess mortality in gout has been attributed to cardiovascular diseases (CVD). Considering the decline in CVD mortality in the general population, we wanted to evaluate overall mortality in gout and cause-specific contributions to mortality beyond CVD and temporal trends. METHODS: All incident cases of gout between 2006 and 2015 in western Sweden and 5 population controls per case matched for age, sex, and county were identified. Comorbidities were identified for 5 years preceding the index date. Follow-up ended at death, migration, or end of study on December 2017. Effect of gout on death risk was calculated using COX regression on the whole population and stratified by sex, adjusted for demographics, and comorbidities. Death incidence rates were compared between the two time periods, 2006–2010 and 2011–2015. RESULTS: We identified 22,055 cases of incident gout and 98,946 controls, median age (Q1, Q3) 69–68 (57, 79/56, 78) years and 67.6–66.5% males. Except for dementia, all comorbidities were significantly more common at baseline among gout cases. Overall, the risk for death in incident gout was neither increased overall nor in men, but women had a 10% elevated risk. In adjusted models for cause-specific mortality, death from CVD, renal disease, and digestive system diseases were significantly increased in the total gout population while death from dementia, cancer, and lung diseases were significantly decreased. There were no significant differences in overall incident death rate ratios between cases and controls in the two time periods examined. CONCLUSIONS: An increased risk for CVD, renal disease, and diseases of the digestive system in patients with gout highlights the importance of addressing CVD risk factors in gout management. Gout was associated with reduced mortality from dementia, which may have implications on urate lowering therapy and possible effects on dementia risk. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907510/ /pubmed/35280894 http://dx.doi.org/10.3389/fmed.2022.802856 Text en Copyright © 2022 Dehlin, Sandström and Jacobsson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Dehlin, Mats
Sandström, Tatiana Zverkova
Jacobsson, Lennart TH
Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title_full Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title_fullStr Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title_full_unstemmed Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title_short Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study
title_sort incident gout: risk of death and cause-specific mortality in western sweden: a prospective, controlled inception cohort study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907510/
https://www.ncbi.nlm.nih.gov/pubmed/35280894
http://dx.doi.org/10.3389/fmed.2022.802856
work_keys_str_mv AT dehlinmats incidentgoutriskofdeathandcausespecificmortalityinwesternswedenaprospectivecontrolledinceptioncohortstudy
AT sandstromtatianazverkova incidentgoutriskofdeathandcausespecificmortalityinwesternswedenaprospectivecontrolledinceptioncohortstudy
AT jacobssonlennartth incidentgoutriskofdeathandcausespecificmortalityinwesternswedenaprospectivecontrolledinceptioncohortstudy